{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:11:27Z","timestamp":1793506287097,"version":"4.5.0"},"reference-count":248,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-097730-B-I00\/MCI\/AEI\/FEDER"],"award-info":[{"award-number":["RTI2018-097730-B-I00\/MCI\/AEI\/FEDER"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AC17\/00029 (ISCIII)\/FEDER."],"award-info":[{"award-number":["AC17\/00029 (ISCIII)\/FEDER."]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The adaptation of adenoviruses as gene delivery tools has resulted in the development of high-capacity adenoviral vectors (HC-AdVs), also known, helper-dependent or \u201cgutless\u201d. Compared with earlier generations (E1\/E3-deleted vectors), HC-AdVs retain relevant features such as genetic stability, remarkable efficacy of in vivo transduction, and production at high titers. More importantly, the lack of viral coding sequences in the genomes of HC-AdVs extends the cloning capacity up to 37 Kb, and allows long-term episomal persistence of transgenes in non-dividing cells. These properties open a wide repertoire of therapeutic opportunities in the fields of gene supplementation and gene correction, which have been explored at the preclinical level over the past two decades. During this time, production methods have been optimized to obtain the yield, purity, and reliability required for clinical implementation. Better understanding of inflammatory responses and the implementation of methods to control them have increased the safety of these vectors. We will review the most significant achievements that are turning an interesting research tool into a sound vector platform, which could contribute to overcome current limitations in the gene therapy field.<\/jats:p>","DOI":"10.3390\/ijms21103643","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T11:31:18Z","timestamp":1590060678000},"page":"3643","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7587-7657","authenticated-orcid":false,"given":"Ana","family":"Ricobaraza","sequence":"first","affiliation":[{"name":"Gene Therapy Program. University of Navarra-CIMA. Navarra Institute of Health Research, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Gonzalez-Aparicio","sequence":"additional","affiliation":[{"name":"Gene Therapy Program. University of Navarra-CIMA. Navarra Institute of Health Research, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mora-Jimenez","sequence":"additional","affiliation":[{"name":"Gene Therapy Program. University of Navarra-CIMA. Navarra Institute of Health Research, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lumbreras","sequence":"additional","affiliation":[{"name":"Gene Therapy Program. University of Navarra-CIMA. Navarra Institute of Health Research, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-2598","authenticated-orcid":false,"given":"Ruben","family":"Hernandez-Alcoceba","sequence":"additional","affiliation":[{"name":"Gene Therapy Program. University of Navarra-CIMA. Navarra Institute of Health Research, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"ref_1","first-page":"195","article-title":"Adenovirus","volume":"343","author":"Smith","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/JCM.42.9.3963-3969.2004","article-title":"Comprehensive Detection and Serotyping of Human Adenoviruses by PCR and Sequencing","volume":"42","author":"Sarantis","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1099\/vir.0.19497-0","article-title":"Genetic content and evolution of adenoviruses","volume":"84","author":"Davison","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/v4050847","article-title":"Latest Insights on Adenovirus Structure and Assembly","volume":"4","year":"2012","journal-title":"Viruses"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-019-08599-y","article-title":"Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions","volume":"10","author":"Baker","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1128\/JVI.01488-15","article-title":"The Intracellular Domain of the Coxsackievirus and Adenovirus Receptor Differentially Influences Adenovirus Entry","volume":"89","author":"Loustalot","year":"2015","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/sj.gt.3303019","article-title":"Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells","volume":"14","author":"Murakami","year":"2007","journal-title":"Gene Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3390\/v6072899","article-title":"Coat as a Dagger: The Use of Capsid Proteins to Perforate Membranes during Non-Enveloped DNA Viruses Trafficking","volume":"6","author":"Bilkova","year":"2014","journal-title":"Viruses"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chom.2011.07.006","article-title":"Drifting Motions of the Adenovirus Receptor CAR and Immobile Integrins Initiate Virus Uncoating and Membrane Lytic Protein Exposure","volume":"10","author":"Burckhardt","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.copbio.2010.06.011","article-title":"Adenovirus: A blueprint for non-viral gene delivery","volume":"21","author":"Chailertvanitkul","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1128\/JVI.02321-10","article-title":"Functional Genetic and Biophysical Analyses of Membrane Disruption by Human Adenovirus","volume":"85","author":"Moyer","year":"2011","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.chom.2011.08.010","article-title":"Kinesin-1-Mediated Capsid Disassembly and Disruption of the Nuclear Pore Complex Promote Virus Infection","volume":"10","author":"Strunze","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Khanal, S., Ghimire, P., and Dhamoon, A. (2018). The Repertoire of Adenovirus in Human Disease: The Innocuous to the Deadly. Biomedicines, 6.","DOI":"10.20944\/preprints201801.0267.v1"},{"key":"ref_14","first-page":"744","article-title":"Incidence and Clinical Manifestations of Adenoviral Infection among Children Undergoing Allogeneic Stem Cell Transplantation","volume":"11","author":"Ephros","year":"2009","journal-title":"IMAJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1002\/1873-3468.13576","article-title":"Adenovirus persistence, reactivation, and clinical management","volume":"593","author":"Lion","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/21645515.2017.1419108","article-title":"Development of novel vaccine vectors: Chimpanzee adenoviral vectors","volume":"14","author":"Guo","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Baker, A., Aguirre-Hern\u00e1ndez, C., Halld\u00e9n, G., and Parker, A. (2018). Designer Oncolytic Adenovirus: Coming of Age. Cancers (Basel), 10.","DOI":"10.20944\/preprints201805.0273.v2"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: The First Effective in Vivo Gene Delivery Vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/1074-7613(94)90074-4","article-title":"MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses","volume":"1","author":"Yang","year":"1994","journal-title":"Immunity"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1080\/21645515.2017.1383575","article-title":"Chimpanzee adenoviral vectors as vaccines for outbreak pathogens","volume":"13","author":"Ewer","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","article-title":"Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons","volume":"96","author":"Morral","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/hum.2013.071","article-title":"Transgene Expression up to 7 Years in Nonhuman Primates Following Hepatic Transduction with Helper-Dependent Adenoviral Vectors","volume":"24","author":"Ng","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.97.3.1002","article-title":"Optimization of the helper-dependent adenovirus system for production and potency in vivo","volume":"97","author":"Sandig","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/jvi.71.4.3293-3298.1997","article-title":"A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging","volume":"71","author":"Parks","year":"1997","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1073\/pnas.93.12.5731","article-title":"A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase","volume":"93","author":"Kochanek","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","article-title":"A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal","volume":"93","author":"Parks","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/89349","article-title":"Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination","volume":"19","author":"Gerdes","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jgm.301","article-title":"Production of helper-dependent adenovirus vector relies on helper virus structure and complementing","volume":"4","author":"Zhou","year":"2002","journal-title":"J. Gene Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/JVI.76.9.4181-4189.2002","article-title":"Cre levels limit packaging signal excision efficiency in the Cre\/loxP helper-dependent adenoviral vector system","volume":"76","author":"Ng","year":"2002","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/gt.2011.58","article-title":"Self-inactivating helper virus for the production of high-capacity adenoviral vectors","volume":"18","author":"Mauleon","year":"2011","journal-title":"Gene Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1515\/BC.1999.184","article-title":"Comparison of the Tamoxifen Regulated Chimeric Cre Recombinases MerCreMer and CreMer","volume":"380","author":"Verrou","year":"1999","journal-title":"Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.gt.3302107","article-title":"Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors","volume":"11","author":"Sargent","year":"2004","journal-title":"Gene Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.virol.2007.05.014","article-title":"Differential amplification of adenovirus vectors by flanking the packaging signal with attB\/attP-\u03a6C31 sequences: Implications for helper-dependent adenovirus production","volume":"367","author":"Alba","year":"2007","journal-title":"Virology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.gt.3301459","article-title":"A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus","volume":"8","author":"Cheshenko","year":"2001","journal-title":"Gene Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0006-291X(03)01256-7","article-title":"An HSV amplicon-based helper system for helper-dependent adenoviral vectors","volume":"307","author":"Kubo","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"No more helper adenovirus: Production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-0934(97)00129-8","article-title":"Complementation of helper-dependent adenoviral vectors: Size effects and titer fluctuations","volume":"68","author":"Alemany","year":"1997","journal-title":"J. Virol. Methods"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/10430340252809810","article-title":"Efficient Rescue of Gutted Adenovirus Genomes Allows Rapid Production of Concentrated Stocks Without Negative Selection","volume":"13","author":"Barjot","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/btpr.25","article-title":"Towards purification of adenoviral vectors based on membrane technology","volume":"24","author":"Peixoto","year":"2008","journal-title":"Biotechnol. Prog."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-4939-7231-9_28","article-title":"Production, Purification, and Titration of First-Generation Adenovirus Vectors","volume":"Volume 1654","author":"Kaufmann","year":"2017","journal-title":"Functional Genomics: Methods in Molecular Biology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jviromet.2010.01.008","article-title":"An efficient process for the purification of helper-dependent adenoviral vector and removal of helper virus by iodixanol ultracentrifugation","volume":"165","author":"Dormond","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105090","DOI":"10.1016\/j.ejps.2019.105090","article-title":"A novel method to purify adenovirus based on increasing salt concentrations in buffer","volume":"141","author":"Ma","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jbiotec.2015.01.030","article-title":"Robust design of adenovirus purification by two-column, simulated moving-bed, size-exclusion chromatography","volume":"213","author":"Nestola","year":"2015","journal-title":"J. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbrc.2008.11.096","article-title":"Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography","volume":"378","author":"Lee","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejps.2014.11.004","article-title":"Chromatographic purification of adenoviral vectors on anion-exchange resins","volume":"67","author":"Bo","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/jvi.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2002.1406","article-title":"Evaluation of Accuracy and Precision of Adenovirus Absorptivity at 260 nm under Conditions of Complete DNA Disruption","volume":"295","author":"Sweeney","year":"2002","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/hum.2006.17.531","article-title":"Quantification of High-Capacity Helper-Dependent Adenoviral Vector Genomes in Vitro and in Vivo, Using Quantitative TaqMan Real-Time Polymerase Chain Reaction","volume":"17","author":"Puntel","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ymthe.2004.06.1013","article-title":"Physical and infectious titers of helper-dependent adenoviral vectors: A method of direct comparison to the adenovirus reference material","volume":"10","author":"Palmer","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/JVI.74.1.505-512.2000","article-title":"Canine Adenovirus Vectors: An Alternative for Adenovirus-Mediated Gene Transfer","volume":"74","author":"Kremer","year":"2000","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/gt.2013.69","article-title":"In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV","volume":"21","author":"Pichard","year":"2014","journal-title":"Gene Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1","volume":"113","author":"Carlisle","year":"2009","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.3107","article-title":"Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement","volume":"19","author":"Xu","year":"2013","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1128\/JVI.78.11.5966-5972.2004","article-title":"Helper-Dependent Adenovirus Vectors Elicit Intact Innate but Attenuated Adaptive Host Immune Responses in Vivo","volume":"78","author":"Muruve","year":"2004","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2741\/1603","article-title":"The induction of inflammation by adenovirus vectors used for gene therapy","volume":"10","author":"Cotter","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/mt.2008.257","article-title":"Efficient, Long-term Hepatic Gene Transfer Using Clinically Relevant HDAd Doses by Balloon Occlusion Catheter Delivery in Nonhuman Primates","volume":"17","author":"Stapleton","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates","volume":"15","author":"Palmer","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.gt.3302792","article-title":"Modulation of TNF\u03b1, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors","volume":"13","author":"Mane","year":"2006","journal-title":"Gene Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1073\/pnas.120474397","article-title":"Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic","volume":"97","author":"Thomas","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.gt.3302819","article-title":"Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector","volume":"14","author":"Oka","year":"2007","journal-title":"Gene Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/sj.mt.6300305","article-title":"One-year Expression from High-capacity Adenoviral Vectors in the Brains of Animals with Pre-existing Anti-adenoviral Immunity: Clinical Implications","volume":"15","author":"Barcia","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.180.6.4098","article-title":"Characterization of Pulmonary T Cell Response to Helper-Dependent Adenoviral Vectors following Intranasal Delivery","volume":"180","author":"Kushwah","year":"2008","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood.V97.1.107","article-title":"Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs","volume":"97","author":"Shirley","year":"2001","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1538-7836.2006.01901.x","article-title":"Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model","volume":"4","author":"Mccormack","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1128\/JVI.77.11.6562-6566.2003","article-title":"Extensive Cross-Reactivity of CD4+ Adenovirus-Specific T Cells: Implications for Immunotherapy and Gene Therapy","volume":"77","author":"Heemskerk","year":"2003","journal-title":"J. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-Associated Virus Vector\u2013Mediated Gene Transfer in Hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/hum.2009.155","article-title":"MyD88-Dependent Silencing of Transgene Expression during the Innate and Adaptive Immune Response to Helper-Dependent Adenovirus","volume":"21","author":"Suzuki","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/hum.2011.002","article-title":"NOD2 Signaling Contributes to the Innate Immune Response against Helper-Dependent Adenovirus Vectors Independently of MyD88 in Vivo","volume":"22","author":"Suzuki","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/mp100216h","article-title":"Species Differences in the Pharmacology and Toxicology of PEGylated Helper-Dependent Adenovirus","volume":"8","author":"Wonganan","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1128\/jvi.65.8.4114-4123.1991","article-title":"The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor","volume":"65","author":"Gooding","year":"1991","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1128\/JVI.76.16.8236-8243.2002","article-title":"Inhibition of Chemokine Expression by Adenovirus Early Region Three (E3) Genes","volume":"76","author":"Lesokhin","year":"2002","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/JVI.02385-06","article-title":"Adenovirus E4 ORF3 Protein Inhibits the Interferon-Mediated Antiviral Response","volume":"81","author":"Ullman","year":"2007","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1089\/hum.2009.020","article-title":"Persistence of High-Capacity Adenoviral Vectors as Replication-Defective Monomeric Genomes in Vitro and in Murine Liver","volume":"20","author":"Jager","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1128\/JVI.77.13.7689-7695.2003","article-title":"Episomal Persistence of Recombinant Adenoviral Vector Genomes during the Cell Cycle in Vivo","volume":"77","author":"Ehrhardt","year":"2003","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11248-010-9401-x","article-title":"Genomic integration of adenoviral gene transfer vectors following transduction of fertilized mouse oocytes","volume":"20","author":"Larochelle","year":"2011","journal-title":"Transgenic Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/v5061500","article-title":"The Role of Chromatin in Adenoviral Vector Function","volume":"5","author":"Wong","year":"2013","journal-title":"Viruses"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/JVI.01787-10","article-title":"Assembly of Helper-Dependent Adenovirus DNA into Chromatin Promotes Efficient Gene Expression","volume":"85","author":"Ross","year":"2011","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1128\/JVI.00796-09","article-title":"Host Cell Detection of Noncoding Stuffer DNA Contained in Helper-Dependent Adenovirus Vectors Leads to Epigenetic Repression of Transgene Expression","volume":"83","author":"Ross","year":"2009","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2002-03-0823","article-title":"Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors","volume":"101","author":"Chuah","year":"2003","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/gt.2015.64","article-title":"Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression","volume":"22","author":"Unzu","year":"2015","journal-title":"Gene Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.gt.3301845","article-title":"Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation","volume":"10","author":"Vigne","year":"2003","journal-title":"Gene Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/JCM.01249-06","article-title":"Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan Africa","volume":"44","author":"Thorner","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jmv.23546","article-title":"Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults","volume":"85","author":"Zhang","year":"2013","journal-title":"J. Med. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1525-0016(02)00017-5","article-title":"Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors","volume":"7","author":"Schiedner","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mt.2012.287","article-title":"SR-A and SREC-I Are Kupffer and Endothelial Cell Receptors for Helper-dependent Adenoviral Vectors","volume":"21","author":"Piccolo","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/liv.12571","article-title":"Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver","volume":"35","author":"Alzuguren","year":"2015","journal-title":"Liver Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/cgt.2009.49","article-title":"Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1\u03b1","volume":"17","author":"Koschel","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/0008-5472.CAN-05-2328","article-title":"Transforming Growth Factor-\u03b2 Receptor Inhibition Enhances Adenoviral Infectability of Carcinoma Cells via Up-Regulation of Coxsackie and Adenovirus Receptor in Conjunction with Reversal of Epithelial-Mesenchymal Transition","volume":"66","author":"Lacher","year":"2006","journal-title":"Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/sj.mt.6300319","article-title":"Comparison of Adenoviruses From Species B, C, E, and F after Intravenous Delivery","volume":"15","author":"Stone","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2012.04.005","article-title":"Adenovirus receptors: Implications for targeting of viral vectors","volume":"33","author":"Arnberg","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01308-08","article-title":"In Vitro and in Vivo Properties of Adenovirus Vectors with Increased Affinity to CD46","volume":"82","author":"Wang","year":"2008","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JVI.01392-12","article-title":"Circulating Antibodies and Macrophages as Modulators of Adenovirus Pharmacology","volume":"87","author":"Khare","year":"2013","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/mt.2011.71","article-title":"Generation of a Kupffer Cell-evading Adenovirus for Systemic and Liver-directed Gene Transfer","volume":"19","author":"Khare","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.3390\/v6083293","article-title":"Fiber-Modified Adenovirus for Central Nervous System Parkinson\u2019s Disease Gene Therapy","volume":"6","author":"Lewis","year":"2014","journal-title":"Viruses"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4161\/cbt.4.11.2084","article-title":"Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system","volume":"4","author":"Stoff","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Yu, D., Jin, C., Ramachandran, M., Xu, J., Nilsson, B., Korsgren, O., Le Blanc, K., Uhrbom, L., Forsberg-Nilsson, K., and Westermark, B. (2013). Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054952"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.mt.6300094","article-title":"Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop","volume":"15","author":"Kritz","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_101","first-page":"2100","article-title":"DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice","volume":"119","author":"Terashima","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Kuhn, I., Harden, P., Bauzon, M., Chartier, C., Nye, J., Thorne, S., Reid, T., Ni, S., Lieber, A., and Fisher, K. (2008). Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002409"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Weaver, E.A., Nehete, P.N., Buchl, S.S., Senac, J.S., Palmer, D., Ng, P., Sastry, K.J., and Barry, M.A. (2009). Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005059"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/sj.gt.3300995","article-title":"Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration","volume":"6","author":"Parks","year":"1999","journal-title":"Gene Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.actbio.2019.06.059","article-title":"Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism","volume":"97","author":"Sun","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.addr.2009.12.003","article-title":"HPMA copolymers for masking and retargeting of therapeutic viruses","volume":"62","author":"Fisher","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/hum.2008.167","article-title":"Cetuximab Retargeting of Adenovirus via the Epidermal Growth Factor Receptor for Treatment of Intraperitoneal Ovarian Cancer","volume":"20","author":"Morrison","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/mt.2010.229","article-title":"Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells","volume":"19","author":"Prill","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2004.03.030","article-title":"Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector","volume":"324","author":"Balamotis","year":"2004","journal-title":"Virology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2010.07.043","article-title":"Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys","volume":"407","author":"Ersching","year":"2010","journal-title":"Virology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.vaccine.2009.10.091","article-title":"Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive","volume":"28","author":"Hutnick","year":"2010","journal-title":"Vaccine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/gt.2010.1","article-title":"Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses","volume":"17","author":"Sharma","year":"2010","journal-title":"Gene Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.01-0321fje","article-title":"Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo","volume":"15","author":"Soudais","year":"2001","journal-title":"FASEB J."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Salinas, S., Bilsland, L.G., Henaff, D., Weston, A.E., Keriel, A., Schiavo, G., and Kremer, E.J. (2009). CAR-Associated Vesicular Transport of an Adenovirus in Motor Neuron Axons. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000442"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/hum.2013.152","article-title":"Central Nervous System Delivery of Helper-Dependent Canine Adenovirus Corrects Neuropathology and Behavior in Mucopolysaccharidosis Type VII Mice","volume":"25","author":"Ariza","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnmol.2019.00071","article-title":"CAV-2 Vector Development and Gene Transfer in the Central and Peripheral Nervous Systems","volume":"12","author":"Beucher","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Zhang, W., Muck-Hausl, M., Wang, J., Sun, C., Gebbing, M., Miskey, C., Ivics, Z., Izsvak, Z., and Ehrhardt, A. (2013). Integration Profile and Safety of an Adenovirus Hybrid-Vector Utilizing Hyperactive Sleeping Beauty Transposase for Somatic Integration. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075344"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/bloodadvances.2017009878","article-title":"Hemophilia gene therapy comes of age","volume":"1","author":"George","year":"2017","journal-title":"Blood Adv."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V95.3.820.003k32_820_828","article-title":"Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector","volume":"95","author":"Zhou","year":"2000","journal-title":"Blood"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0037-1615881","article-title":"Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A","volume":"82","author":"Zhang","year":"1999","journal-title":"Thromb. Haemost."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1182\/blood-2003-05-1426","article-title":"Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A","volume":"103","author":"Brown","year":"2004","journal-title":"Blood"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1073\/pnas.1015571108","article-title":"Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1538-7836.2004.00552.x","article-title":"Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice","volume":"2","author":"Brown","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood-2012-10-462200","article-title":"Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant","volume":"121","author":"McIntosh","year":"2013","journal-title":"Blood"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Callan, M.B., Haskins, M.E., Wang, P., Zhou, S., High, K.A., and Arruda, V.R. (2016). Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151800"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.omtm.2018.12.007","article-title":"Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy","volume":"12","author":"Arruda","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood.V99.11.3923","article-title":"A new adenoviral helper\u2013dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo","volume":"99","author":"Ehrhardt","year":"2002","journal-title":"Blood"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood-2003-01-0314","article-title":"A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia","volume":"102","author":"Ehrhardt","year":"2003","journal-title":"Blood"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/hum.2005.16.811","article-title":"Sustained Phenotypic Correction of Canine Hemophilia B after Systemic Administration of Helper-Dependent Adenoviral Vector","volume":"16","author":"Nichols","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/mt.2012.143","article-title":"Balloon Catheter Delivery of Helper-dependent Adenoviral Vector Results in Sustained, Therapeutic hFIX Expression in Rhesus Macaques","volume":"20","author":"Liou","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1089\/hum.1998.9.18-2709","article-title":"High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of \u03b1 1 -Antitrypsin with Negligible Toxicity","volume":"9","author":"Morral","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03402113","article-title":"Toxicity Associated with Repeated Administration of First-Generation Adenovirus Vectors Does Not Occur with a Helper-Dependent Vector","volume":"6","author":"Zhou","year":"2000","journal-title":"Mol. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1073\/pnas.241506298","article-title":"Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/gt.2013.38","article-title":"PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice","volume":"20","author":"Leggiero","year":"2013","journal-title":"Gene Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gene.2003.11.024","article-title":"Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice","volume":"327","author":"Pastore","year":"2004","journal-title":"Gene"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.CIR.0000066913.69844.B2","article-title":"Long-Term Stable Expression of Human Apolipoprotein A-I Mediated by Helper-Dependent Adenovirus Gene Transfer Inhibits Atherosclerosis Progression and Remodels Atherosclerotic Plaques in a Mouse Model of Familial Hypercholesterolemia","volume":"107","author":"Belalcazar","year":"2003","journal-title":"Circulation"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/ATVBAHA.117.309565","article-title":"Apo A-I (Apolipoprotein A-I) Vascular Gene Therapy Provides Durable Protection against Atherosclerosis in Hyperlipidemic Rabbits","volume":"38","author":"Wacker","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/hum.2018.120","article-title":"ABCA1 Overexpression in Endothelial Cells in Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation","volume":"30","author":"Stamatikos","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.gt.3302310","article-title":"Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia","volume":"11","author":"Nomura","year":"2004","journal-title":"Gene Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/gt.2014.85","article-title":"Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector","volume":"22","author":"Oka","year":"2015","journal-title":"Gene Ther."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: Overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/TP.0b013e3181a27939","article-title":"Transplantation Procedures in Children with Primary Hyperoxaluria Type 1: Outcome and Longitudinal Growth","volume":"87","author":"Brinkert","year":"2009","journal-title":"Transplantation"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/gt.2015.107","article-title":"Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1","volume":"23","author":"Castello","year":"2016","journal-title":"Gene Ther."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2018.04.001","article-title":"Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy","volume":"124","author":"Khoja","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s11262-017-1471-x","article-title":"Gene therapy with helper-dependent adenoviral vectors: Lessons from studies in large animal models","volume":"53","author":"Ng","year":"2017","journal-title":"Virus Genes"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/erm.2016.18","article-title":"Emerging therapies for acute intermittent porphyria","volume":"18","author":"Fontanellas","year":"2016","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddt148","article-title":"Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice","volume":"22","author":"Unzu","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5483\/BMBRep.2015.48.8.101","article-title":"Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases","volume":"48","author":"Oh","year":"2015","journal-title":"BMB Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymthe.2005.08.006","article-title":"Fully Deleted Adenovirus Persistently Expressing GAA Accomplishes Long-Term Skeletal Muscle Glycogen Correction in Tolerant and Nontolerant GSD-II Mice","volume":"13","author":"Kiang","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/gt.2016.53","article-title":"Long-term, high-level hepatic secretion of acid \u03b1-glucosidase for Pompe disease achieved in non-human primates using helper-dependent adenovirus","volume":"23","author":"Rastall","year":"2016","journal-title":"Gene Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"290","DOI":"10.21037\/atm.2019.05.56","article-title":"Pompe disease gene therapy: Neural manifestations require consideration of CNS directed therapy","volume":"7","author":"Byrne","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jviromet.2006.03.031","article-title":"Improved high-capacity adenoviral vectors for high-level neuron-restricted gene transfer to the CNS","volume":"136","author":"Hermening","year":"2006","journal-title":"J. Virol. Methods"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/hgtb.2012.060","article-title":"Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial","volume":"23","author":"Xiong","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1089\/hgtb.2015.168","article-title":"Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn \u201cOn\u201d Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model","volume":"27","author":"VanderVeen","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.2000.0104","article-title":"Prolonged Transgene Expression Mediated by a Helper-Dependent Adenoviral Vector (hdAd) in the Central Nervous System","volume":"2","author":"Zou","year":"2000","journal-title":"Mol. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.gt.3303050","article-title":"Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates","volume":"15","author":"Butti","year":"2008","journal-title":"Gene Ther."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Piersanti, S., Astrologo, L., Licursi, V., Costa, R., Roncaglia, E., Gennetier, A., Ibanes, S., Chillon, M., Negri, R., and Tagliafico, E. (2013). Differentiated Neuroprogenitor Cells Incubated with Human or Canine Adenovirus, or Lentiviral Vectors Have Distinct Transcriptome Profiles. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069808"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2007.05.019","article-title":"Different modulation of cellular transcription by adenovirus 5, \u0394E1\/E3 adenovirus and helper-dependent vectors","volume":"130","author":"Martina","year":"2007","journal-title":"Virus Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/104303401750148829","article-title":"Preexisting Antiadenoviral Immunity is Not a Barrier to Efficient and Stable Transduction of the Brain, Mediated by Novel High-Capacity Adenovirus Vectors","volume":"12","author":"Thomas","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156652307782151498","article-title":"Immune Responses to Adenovirus and Adeno-Associated Vectors Used for Gene Therapy of Brain Diseases: The Role of Immunological Synapses in Understanding the Cell Biology of Neuroimmune Interactions","volume":"7","author":"Lowenstein","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/JVI.80.1.27-37.2006","article-title":"Regulatable Gutless Adenovirus Vectors Sustain Inducible Transgene Expression in the Brain in the Presence of an Immune Response against Adenoviruses","volume":"80","author":"Xiong","year":"2006","journal-title":"J. Virol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mt.6300375","article-title":"Immunization against the Transgene but not the TetON Switch Reduces Expression from Gutless Adenoviral Vectors in the Brain","volume":"16","author":"Xiong","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1128\/JVI.00232-08","article-title":"High-Capacity Adenovirus Vector-Mediated Anti-Glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity","volume":"82","author":"King","year":"2008","journal-title":"J. Virol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1128\/JVI.00398-10","article-title":"A Novel Bicistronic High-Capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-Inducible Expression of Flt3L for Glioma Therapeutics","volume":"84","author":"Puntel","year":"2010","journal-title":"J. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/jvi.71.1.145-151.1997","article-title":"The immunogenicity of intracerebral virus infection depends on anatomical site","volume":"71","author":"Stevenson","year":"1997","journal-title":"J. Virol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0301-0082(98)00014-8","article-title":"Inflammation in the CNS: Balance between immunological privilege and immune responses","volume":"56","author":"Matyszak","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0306-4522(96)00160-1","article-title":"The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system","volume":"74","author":"Matyszak","year":"1996","journal-title":"Neuroscience"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2006.11.007","article-title":"What is the blood\u2013brain barrier (not)?","volume":"28","author":"Bechmann","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6","article-title":"Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations","volume":"405","author":"McMenamin","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"11284","DOI":"10.1128\/JVI.75.23.11284-11291.2001","article-title":"Reducing the Native Tropism of Adenovirus Vectors Requires Removal of both CAR and Integrin Interactions","volume":"75","author":"Einfeld","year":"2001","journal-title":"J. Virol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1074\/jbc.M113.518365","article-title":"Disruption of the Coxsackievirus and Adenovirus Receptor-Homodimeric Interaction Triggers Lipid Microdomain- and Dynamin-dependent Endocytosis and Lysosomal Targeting","volume":"289","author":"Salinas","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e1304790","DOI":"10.1080\/23262133.2017.1304790","article-title":"What is CAR doing in the middle of the adult neurogenic road?","volume":"4","author":"Salinas","year":"2017","journal-title":"Neurogenesis"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus Receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1523\/JNEUROSCI.0132-16.2016","article-title":"Coxsackievirus Adenovirus Receptor Loss Impairs Adult Neurogenesis, Synapse Content, and Hippocampus Plasticity","volume":"36","author":"Zussy","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_175","first-page":"1","article-title":"Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate","volume":"3","author":"Serratrice","year":"2018","journal-title":"JCI Insight"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-005-9055-3","article-title":"Cell type- and region- dependent coxsackie adenovirus receptor expression in the central nervous system","volume":"78","author":"Persson","year":"2006","journal-title":"J. Neurooncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/95.9.652","article-title":"Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway","volume":"95","author":"Fueyo","year":"2003","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-3806(03)00035-X","article-title":"Developmental distribution of coxsackie virus and adenovirus receptor localized in the nervous system","volume":"143","author":"Hotta","year":"2003","journal-title":"Dev. Brain Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0168-1702(94)00100-Q","article-title":"Receptor proteins on newborn Balb\/c mouse brain cells for coxsackievirus B3 are immunologically distinct from those on HeLa cells","volume":"35","author":"Xu","year":"1995","journal-title":"Virus Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00441-013-1713-8","article-title":"Coxsackievirus and adenovirus receptor-positive cells compose the putative stem\/progenitor cell niches in the marginal cell layer and parenchyma of the rat anterior pituitary","volume":"354","author":"Chen","year":"2013","journal-title":"Cell Tissue Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"103726","DOI":"10.1016\/j.dib.2019.103726","article-title":"Data on localization of coxsackievirus and adenovirus receptor (CAR) in the embryonic rat brain","volume":"23","author":"Chen","year":"2019","journal-title":"Data Br."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ymthe.2006.05.006","article-title":"Effective High-Capacity Gutless Adenoviral Vectors Mediate Transgene Expression in Human Glioma Cells","volume":"14","author":"Candolfi","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1097\/PR9.0000000000000695","article-title":"Gene therapy for neuropathic pain using dorsal root ganglion\u2013targeted helper-dependent adenoviral vectors with GAD67 expression","volume":"3","author":"Ogawa","year":"2018","journal-title":"PAIN Rep."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature14600","article-title":"Viral-genetic tracing of the input\u2013output organization of a central noradrenaline circuit","volume":"524","author":"Schwarz","year":"2015","journal-title":"Nature"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(94)91919-4","article-title":"Adenoviral vectors as functional retrograde neuronal tracers","volume":"648","author":"Ridoux","year":"1994","journal-title":"Brain Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2012.10.011","article-title":"DREADDing the lateral habenula: A review of methodological approaches for studying lateral habenula function","volume":"1511","author":"Nair","year":"2013","journal-title":"Brain Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neurobiolaging.2018.02.008","article-title":"Age-related pathology after adenoviral overexpression of the leucine-rich repeat kinase 2 in the mouse striatum","volume":"66","author":"Kritzinger","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/jgm.2641","article-title":"Adenovirus vector-based in vitro neuronal cell model for Huntington\u2019s disease with human disease-like differential aggregation and degeneration","volume":"14","author":"Dong","year":"2012","journal-title":"J. Gene Med."},{"key":"ref_190","first-page":"342","article-title":"The astrocyte odyssey","volume":"86","author":"Wang","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy","volume":"15","author":"Verhaart","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/mt.2008.23","article-title":"Transduction of Full-length Dystrophin to Multiple Skeletal Muscles Improves Motor Performance and Life Span in Utrophin\/Dystrophin Double Knockout Mice","volume":"16","author":"Kawano","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ymthe.2004.07.020","article-title":"Sustained Muscle Expression of Dystrophin from a High-Capacity Adenoviral Vector with Systemic Gene Transfer of T Cell Costimulatory Blockade","volume":"10","author":"Jiang","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/mt.2011.58","article-title":"Rescue from Respiratory Dysfunction by Transduction of Full-length Dystrophin to Diaphragm via the Peritoneal Cavity in Utrophin\/Dystrophin Double Knockout Mice","volume":"19","author":"Ishizaki","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ymthe.2005.11.018","article-title":"Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: Robust dystrophin synthesis in duchenne muscular dystrophy muscle cells","volume":"13","author":"Holkers","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.2012.003","article-title":"Capsid-Modified Adenoviral Vectors for Improved Muscle-Directed Gene Therapy","volume":"23","author":"Guse","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMc1606202","article-title":"TARGT Gene Therapy Platform for Correction of Anemia in End-Stage Renal Disease","volume":"376","author":"Blum","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/humc.2015.125","article-title":"Preclinical and Preliminary Clinical Evaluation of Genetically Transduced Dermal Tissue Implants for the Sustained Secretion of Erythropoietin and Interferon \u03b1","volume":"26","author":"Shapir","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2018.10.017","article-title":"Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases","volume":"291","author":"Sherbo","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/gt.2010.75","article-title":"Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: Long-term transgene expression in immunocompetent mice","volume":"17","author":"Gil","year":"2010","journal-title":"Gene Ther."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1038\/mtna.2016.44","article-title":"A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration","volume":"5","author":"Boehme","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1038\/mtm.2014.57","article-title":"Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5\/35 vectors expressing site-specific endonucleases under microRNA regulation","volume":"2","author":"Saydaminova","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.omtm.2020.01.014","article-title":"A Single \u201cAll-in-One\u201d Helper-Dependent Adenovirus to Deliver Donor DNA and CRISPR\/Cas9 for Efficient Homology-Directed Repair","volume":"17","author":"Palmer","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymthe.2019.08.018","article-title":"dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice","volume":"28","author":"Colasante","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41551-019-0357-8","article-title":"Adenine base editing in an adult mouse model of tyrosinaemia","volume":"4","author":"Song","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymthe.2020.01.005","article-title":"Treatment of a Mouse Model of ALS by in Vivo Base Editing","volume":"28","author":"Lim","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Xia, E., Zhang, Y., Cao, H., Li, J., Duan, R., and Hu, J. (2019). TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy. Genes (Basel), 10.","DOI":"10.3390\/genes10010039"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.omtn.2018.10.015","article-title":"Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction","volume":"13","author":"Xia","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nmeth.3075","article-title":"Adenoviral vector DNA for accurate genome editing with engineered nucleases","volume":"11","author":"Holkers","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1038\/mtna.2016.83","article-title":"Homology Requirements for Efficient, Footprintless Gene Editing at the CFTR Locus in Human iPSCs with Helper-dependent Adenoviral Vectors","volume":"5","author":"Palmer","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"13628","DOI":"10.1073\/pnas.0506598102","article-title":"Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors","volume":"102","author":"Ohbayashi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature13864","article-title":"Promoterless gene targeting without nucleases ameliorates haemophilia B in mice","volume":"517","author":"Barzel","year":"2015","journal-title":"Nature"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1038\/mtna.2013.55","article-title":"Efficient Gene Delivery to Pig Airway Epithelia and Submucosal Glands Using Helper-Dependent Adenoviral Vectors","volume":"2","author":"Cao","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing Airway Basal Cells with a Helper-Dependent Adenoviral Vector for Lung Gene Therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.omtm.2019.10.003","article-title":"Bi-allelic Homology-Directed Repair with Helper-Dependent Adenoviruses","volume":"15","author":"Palmer","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1873-3468.13668","article-title":"Adenovirus vectors in hematopoietic stem cell genome editing","volume":"593","author":"Li","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.omtm.2018.04.008","article-title":"HDAd5\/35++ Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR\/Cas9 Toxicity in Human Hematopoietic Stem Cells","volume":"9","author":"Li","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2018-03-838540","article-title":"Reactivation of \u03b3-globin in adult \u03b2-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing","volume":"131","author":"Li","year":"2018","journal-title":"Blood"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.ymthe.2019.08.006","article-title":"Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after in Vivo HSC Transduction with HDAd5\/35++ Vectors","volume":"27","author":"Li","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/bloodadvances.2019000706","article-title":"High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells","volume":"3","author":"Wang","year":"2019","journal-title":"Blood Adv."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: An ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/JVI.79.5.3146-3162.2005","article-title":"Transfer of the Full-Length Dystrophin-Coding Sequence into Muscle Cells by a Dual High-Capacity Hybrid Viral Vector with Site-Specific Integration Ability","volume":"79","author":"Goncalves","year":"2005","journal-title":"J. Virol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/nar\/gkv1540","article-title":"Selection-free gene repair after adenoviral vector transduction of designer nucleases: Rescue of dystrophin synthesis in DMD muscle cell populations","volume":"44","author":"Maggio","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/clpt.2009.260","article-title":"Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma","volume":"88","author":"Muhammad","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_228","first-page":"223","article-title":"Helper-dependent adenoviral vectors as gene delivery vehicles","volume":"3","author":"Morsy","year":"1999","journal-title":"Gene Ther. Mol. Biol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/gut.2010.211722","article-title":"Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice","volume":"60","author":"Alzuguren","year":"2011","journal-title":"Gut"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gt.2015.45","article-title":"Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model","volume":"22","author":"Poutou","year":"2015","journal-title":"Gene Ther."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.10.032","article-title":"Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment","volume":"268","author":"Poutou","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.172.3.1524","article-title":"Early Adenoviral Gene Expression Mediates Immunosuppression by Transduced Dendritic Cell (DC): Implications for Immunotherapy Using Genetically Modified DC","volume":"172","author":"Tuettenberg","year":"2004","journal-title":"J. Immunol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/jgm.1629","article-title":"High-capacity adenoviral vectors circumvent the limitations of \u0394E1 and \u0394E1\/\u0394E3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses","volume":"13","author":"Kron","year":"2011","journal-title":"J. Gene Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jgm.1627","article-title":"\u0394E1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum","volume":"13","author":"Zong","year":"2011","journal-title":"J. Gene Med."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/sj.gt.3302332","article-title":"Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL","volume":"11","author":"Harui","year":"2004","journal-title":"Gene Ther."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/COH.0b013e32833d2d2b","article-title":"Overview of STEP and Phambili trial results: Two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag\/pol\/nef subtype B HIV vaccine","volume":"5","author":"Gray","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1080\/14760584.2019.1690458","article-title":"Strategies for inducing effective neutralizing antibody responses against HIV-1","volume":"18","author":"Sliepen","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4172\/2155-6113.1000461","article-title":"Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals","volume":"6","author":"Fuchs","year":"2015","journal-title":"J. AIDS Clin. Res."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/M15-0880","article-title":"Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial","volume":"164","author":"Baden","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: A randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"Gurwith","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Khurana, S., Coyle, E.M., Manischewitz, J., King, L.R., Ishioka, G., Alexander, J., Smith, J., Gurwith, M., and Golding, H. (2015). Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0115476"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1410863","article-title":"Chimpanzee Adenovirus Vector Ebola Vaccine","volume":"376","author":"Ledgerwood","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/22221751.2019.1644968","article-title":"Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques","volume":"8","author":"Yang","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/22221751.2019.1620083","article-title":"Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection","volume":"8","author":"Jia","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_245","first-page":"1","article-title":"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: A dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","volume":"3099","author":"Folegatti","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1128\/JVI.79.11.6772-6780.2005","article-title":"Regulated and Liver-Specific Tamarin Alpha Interferon Gene Delivery by a Helper-Dependent Adenoviral Vector","volume":"79","author":"Aurisicchio","year":"2005","journal-title":"J. Virol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/JVI.02384-08","article-title":"Treatment of Chronic Viral Hepatitis in Woodchucks by Prolonged Intrahepatic Expression of Interleukin-12","volume":"83","author":"Crettaz","year":"2009","journal-title":"J. Virol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.omtn.2018.05.006","article-title":"One-Vector System for Multiplexed CRISPR\/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors","volume":"12","author":"Schiwon","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/10\/3643\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:31:06Z","timestamp":1760175066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/10\/3643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":248,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["ijms21103643"],"URL":"https:\/\/doi.org\/10.3390\/ijms21103643","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]}}}